Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
111
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Arcturus Therapeutics Holdings Inc market cap is $214.73M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Arcturus Therapeutics Holdings Inc 52 week high is $17.96 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Arcturus Therapeutics Holdings Inc 52 week low is $5.50 as of November 22, 2026.
Arcturus Therapeutics Holdings Inc stock price today is $7.45.
Arcturus Therapeutics Holdings Inc stock price yesterday was $7.60.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Arcturus Therapeutics Holdings Inc's P/E ratio is -2.42.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Arcturus Therapeutics Holdings Inc P/B ratio is 1.2567.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Arcturus Therapeutics Holdings Inc 50-day moving average is $11.72.
Arcturus Therapeutics Holdings Inc has 111 employees.